rs772161607
Variant summary
Our verdict is Benign. Variant got -7 ACMG points: 0P and 7B. BP4_ModerateBP6BS2
The NM_000240.4(MAOA):c.1248G>A(p.Met416Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000289 in 1,209,823 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 14 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_000240.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -7 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
MAOA | NM_000240.4 | c.1248G>A | p.Met416Ile | missense_variant | 12/15 | ENST00000338702.4 | |
MAOA | NM_001270458.2 | c.849G>A | p.Met283Ile | missense_variant | 13/16 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
MAOA | ENST00000338702.4 | c.1248G>A | p.Met416Ile | missense_variant | 12/15 | 1 | NM_000240.4 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000161 AC: 18AN: 111744Hom.: 0 Cov.: 24 AF XY: 0.000206 AC XY: 7AN XY: 33920
GnomAD3 exomes AF: 0.0000657 AC: 12AN: 182756Hom.: 0 AF XY: 0.000119 AC XY: 8AN XY: 67348
GnomAD4 exome AF: 0.0000155 AC: 17AN: 1098027Hom.: 0 Cov.: 36 AF XY: 0.0000193 AC XY: 7AN XY: 363429
GnomAD4 genome AF: 0.000161 AC: 18AN: 111796Hom.: 0 Cov.: 24 AF XY: 0.000206 AC XY: 7AN XY: 33982
ClinVar
Submissions by phenotype
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | Sep 25, 2015 | - - |
Brunner syndrome Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 28, 2021 | This sequence change replaces methionine, which is neutral and non-polar, with isoleucine, which is neutral and non-polar, at codon 416 of the MAOA protein (p.Met416Ile). This variant is present in population databases (rs772161607, gnomAD 0.06%), and has an allele count higher than expected for a pathogenic variant. This variant has not been reported in the literature in individuals affected with MAOA-related conditions. ClinVar contains an entry for this variant (Variation ID: 282807). Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be tolerated. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Inborn genetic diseases Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 09, 2021 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at